Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
MicroVision Inc

Start price
Target price
Perf. (%)
€9.50
01.10.21
-
01.10.22
-58.63%
13.03.22

buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€2.46
30.09.21
-
30.09.22
0.00%
02.10.21

Risky Investment
buy
Deciphera Pharmaceuticals

Start price
Target price
Perf. (%)
€28.40
29.09.21
€40.00
31.12.24
-67.96%
05.11.21

Could be very worthwhile Investment >20% year
buy
Flexion Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.40
29.09.21
€10.00
31.12.24
43.52%
11.10.21

Could be very worthwhile Investment >20% year
Editas Medicine Inc

Start price
Target price
Perf. (%)
€46.67
29.09.21
€35.00
31.10.22
-16.73%
29.09.21

Could be very worthwhile Investment >20% year
buy
Insmed Inc.

Start price
Target price
Perf. (%)
€23.60
27.09.21
€40.00
31.12.23
-25.00%
08.05.23

Could be very worthwhile Investment >20% year
buy
Genfit S.A.

Start price
Target price
Perf. (%)
€3.36
26.09.21
-
26.09.22
14.15%
27.09.22

Could be worthwhile Investment >10% per year
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€5.55
20.09.21
€4.00
20.09.22
-13.87%
30.09.21

Good culture
Probably not worthwhile Investment
Below average Management
Little innovation
buy
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€5.50
20.09.21
-
20.09.22
29.09%
21.09.21

Could be worthwhile Investment >10% per year
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€2.84
20.09.21
€4.00
20.09.22
-13.38%
02.10.21

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€5.20
20.09.21
€4.00
20.09.22
-22.69%
22.10.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Innovative
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€34.22
20.09.21
€60.00
31.12.23
-88.71%
08.05.23

Could be very worthwhile Investment >20% year
MacroGenics Inc.

Start price
Target price
Perf. (%)
€16.79
19.09.21
-
19.09.22
-79.51%
20.09.22

Probably not worthwhile Investment
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€25.05
19.09.21
-
19.09.22
-85.23%
20.09.22

Growths faster than the competition
Risky Investment
buy
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€5.20
18.09.21
€10.00
31.12.23
-79.42%
08.05.23

Could be very worthwhile Investment >20% year
buy
Spectrum Pharmaceuticals

Start price
Target price
Perf. (%)
€2.60
18.09.21
€5.00
31.12.23
-62.67%
08.05.23

Could be very worthwhile Investment >20% year
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€5.20
18.09.21
€2.00
18.09.22
-22.69%
02.10.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€3.00
17.09.21
-
17.09.22
73.33%
19.09.21

Risky Investment
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€2.94
15.09.21
-
15.09.22
0.00%
19.09.21

Risky Investment
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€3.50
14.09.21
-
14.09.22
-30.29%
05.10.21

Innovative
buy
Assembly Biosciences Inc.

Start price
Target price
Perf. (%)
€2.76
12.09.21
€3.00
12.09.22
-24.82%
13.09.22

Could be worthwhile Investment >10% per year
buy
Seres Therapeutics Inc

Start price
Target price
Perf. (%)
€4.99
12.09.21
€8.00
12.09.22
36.81%
13.09.22

Could be worthwhile Investment >10% per year
buy
Pro-Dex Inc.

Start price
Target price
Perf. (%)
€20.00
12.09.21
€23.00
12.09.22
-1.50%
13.09.22

Could be worthwhile Investment >10% per year
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€19.47
09.09.21
€25.00
31.12.23
-67.12%
08.05.23

Could be very worthwhile Investment >20% year
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€3.44
08.09.21
-
08.09.22
-34.88%
08.12.21

Could be worthwhile Investment >10% per year